Salesforce just got a vote of confidence from one of Wall Street’s sharpest firms — and the timing couldn’t be more significant. Guggenheim upgraded Salesforce (NYSE: CRM) to Buy from Neutral on July 1, setting a price target of $228. That’s a substantial premium to where the stock has been trading, and it signals something important: the narrative that AI would eat Salesforce’s lunch is starting to look wrong.
The bear case on CRM has been simple but loud. The argument goes that AI-powered tools — especially autonomous agents and large language models — would let companies automate away the need for expensive CRM software. Salesforce, the thinking went, would be disrupted by the very AI wave it was trying to ride. The stock shed significant ground in the first half of 2026, with shares down roughly 38% from their peak. But Guggenheim and other analysts who’ve looked closely at the numbers are reaching a different conclusion. Salesforce is not being replaced by AI — it’s becoming the infrastructure that runs AI workflows inside enterprise organizations. Its Agentforce platform, which lets businesses deploy AI agents across sales, service, and marketing, is gaining real traction. Early customer adoption data and pipeline signals suggest Agentforce is converting from demo to deployment faster than skeptics expected. Meanwhile, Salesforce’s sticky, subscription-based revenue model gives it a durability that flashier AI-pure plays can’t match — over 90% of its revenue recurs annually across more than 150,000 business customers worldwide.
For retail investors, the setup is straightforward: you have a blue-chip enterprise software company with approximately $34 billion in annual revenue, a strong balance sheet with over $8 billion in cash, and a $228 analyst price target against a stock that’s been beaten down on fears that haven’t materialized. Guggenheim’s upgrade is a signal that sentiment is beginning to turn. Salesforce won’t double overnight — it’s a $200 billion+ market cap business, not a spec play. But at current prices, investors are getting one of the most dominant B2B software franchises on the planet at a meaningful discount to where leading analysts think it belongs. For long-term portfolios, this looks like a window worth considering carefully.
